The safety and efficacy of tislelizumab, alone or in combination with chemotherapy, for the treatment of non-small cell lung cancer: a systematic review of clinical trials
Research output: Contribution to journal › Article › peer-review
Fingerprint
Dive into the research topics of 'The safety and efficacy of tislelizumab, alone or in combination with chemotherapy, for the treatment of non-small cell lung cancer: a systematic review of clinical trials'. Together they form a unique fingerprint.